These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1987387)

  • 1. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial.
    McCollum C; Alexander C; Kenchington G; Franks PJ; Greenhalgh R
    J Vasc Surg; 1991 Jan; 13(1):150-61; discussion 161-2. PubMed ID: 1987387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients.
    Monaco M; Di Tommaso L; Pinna GB; Lillo S; Schiavone V; Stassano P
    J Vasc Surg; 2012 Jul; 56(1):96-105. PubMed ID: 22551909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: long-term results.
    Rosenthal D; Mittenthal MJ; Ruben DM; Jones DH; Estes JW; Stanton PE; Lamis PA
    Am Surg; 1987 Sep; 53(9):477-81. PubMed ID: 3631756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suggested treatment protocol for improving patency of femoral-infrapopliteal cryopreserved saphenous vein allografts.
    Buckley CJ; Abernathy S; Lee SD; Arko FR; Patterson DE; Manning LG
    J Vasc Surg; 2000 Oct; 32(4):731-8. PubMed ID: 11013037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internal mammary artery and saphenous vein graft patency. Effects of aspirin.
    Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Kern KB; Sethi G; Sharma GV; Khuri S
    Circulation; 1990 Nov; 82(5 Suppl):IV237-42. PubMed ID: 2225410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
    Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA
    J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
    Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y
    Circulation; 1989 Nov; 80(5):1190-7. PubMed ID: 2680158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.
    Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y
    Circulation; 1988 Jun; 77(6):1324-32. PubMed ID: 3286040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA).
    Cataldo G; Braga M; Pirotta N; Lavezzari M; Rovelli F; Marubini E
    Circulation; 1993 Nov; 88(5 Pt 2):II93-8. PubMed ID: 8222202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dipyridamole plus aspirin on hemodialysis graft patency.
    Dixon BS; Beck GJ; Vazquez MA; Greenberg A; Delmez JA; Allon M; Dember LM; Himmelfarb J; Gassman JJ; Greene T; Radeva MK; Davidson IJ; Ikizler TA; Braden GL; Fenves AZ; Kaufman JS; Cotton JR; Martin KJ; McNeil JW; Rahman A; Lawson JH; Whiting JF; Hu B; Meyers CM; Kusek JW; Feldman HI;
    N Engl J Med; 2009 May; 360(21):2191-201. PubMed ID: 19458364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTFE or HUV for femoro-popliteal bypass: a multi-centre trial.
    McCollum C; Kenchington G; Alexander C; Franks PJ; Greenhalgh RM
    Eur J Vasc Surg; 1991 Aug; 5(4):435-43. PubMed ID: 1915909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial.
    Klinkert P; Schepers A; Burger DH; van Bockel JH; Breslau PJ
    J Vasc Surg; 2003 Jan; 37(1):149-55. PubMed ID: 12514593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting.
    Edmondson RA; Cohen AT; Das SK; Wagner MB; Kakkar VV
    Lancet; 1994 Oct; 344(8927):914-8. PubMed ID: 7934346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
    van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI
    J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
    Sharma GV; Khuri SF; Josa M; Folland ED; Parisi AF
    Circulation; 1983 Sep; 68(3 Pt 2):II218-21. PubMed ID: 6347428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superficial femoral-popliteal veins and reversed saphenous veins as primary femoropopliteal bypass grafts: a randomized comparative study.
    Schulman ML; Badhey MR; Yatco R
    J Vasc Surg; 1987 Jul; 6(1):1-10. PubMed ID: 3599276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indobufen vs acetylsalicylic acid plus dipyridamole in long-term patency after femoropopliteal bypass.
    D'Addato M; Curti T; Bertini D; Donini I; Ferrero R; Fiorani P; Pellegrino F; Vecchioni R; Visconti W; Zinicola N
    Int Angiol; 1992; 11(2):106-12. PubMed ID: 1402213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
    Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P
    Lancet; 1989 Jul; 2(8653):1-7. PubMed ID: 2567792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting.
    London NJ; Varty K; Thompson M; Sayers RD; Bell PR
    Lancet; 1994 Dec; 344(8936):1571-2. PubMed ID: 7848483
    [No Abstract]   [Full Text] [Related]  

  • 20. A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting.
    Burger DH; Kappetein AP; Van Bockel JH; Breslau PJ
    J Vasc Surg; 2000 Aug; 32(2):278-83. PubMed ID: 10917987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.